Boston Scientific Corporation ($BSX) Stock Forecast: Down 0.5% Today

What is Boston Scientific Corporation?

Boston Scientific Corporation (NYSE: BSX) is a leading global medical technology company that advances science for life by providing a broad range of high-performance solutions. Today, BSX experienced a strong bearish movement in the market.

Why is Boston Scientific Corporation going down?

BSX stock is down 0.5% on Jul 1, 2024 14:51

• A conference call was announced by Boston Scientific to discuss its second-quarter 2024 results, which could have heightened investor anticipation and led to profit-taking.
• The positive news of securing a CE Mark for the DBS image-guided programming software might not have been sufficient to offset broader market trends or specific company performance concerns.
• The overall bearish movement in the market, particularly in the healthcare sector, could have influenced BSX's downward trajectory despite the positive developments within the company.
• The sector rotation away from tech and towards healthcare might have created uncertainty and volatility for BSX and contributed to the bearish market movement.

BSX Price Chart

BSX News

Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results | BSX Stock News

Boston Scientific to unveil Q2 2024 financial results in a live webcast on July 24 at 8:00 a.m. ET. Join CEO and CFO for critical business insights. Don''t miss it!

https://www.stocktitan.net/news/BSX/boston-scientific-announces-conference-call-discussing-second-klf0fbsf82ur.html

Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results

MARLBOROUGH, Mass., July 1, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, at 8:00 a.m. ET. The call will be…

https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-second-quarter-2024-results-302185403.html

Boston Scientific ( BSX ) Ascends While Market Falls: Some Facts to Note

In the latest trading session, Boston Scientific (BSX) closed at $77.01, marking a +0.01% move from the previous day.

https://www.zacks.com/stock/news/2295290/boston-scientific-bsx-ascends-while-market-falls-some-facts-to-note

7 Biotech Stocks to Boost Your Portfolio to Peak Health

While innovations such as artificial intelligence have become all the rage, there’s another type of technology – biotechnology – that deserves careful consideration for your portfolio. Indeed, if you haven’t considered the sector, it’s really time to focus on biotech stocks. First, let’s get the obvious matter out of the way: biotech stocks benefit broadly from a permanently relevant narrative. That doesn’t mean individual companies are guaranteed to rise. It’s just that the concept of addressing diseases and chronic conditions is effectively eternal. A thousand years from now, you can probably bet that people are investing in healthcare enterprises. Second, biotech stocks enjoy a massive total addressable market. According to Grand View Research, the global sector reached a valuation of $1.55 trillion last year. By 2030, the ecosystem could be worth $3.88 trillion. If so, that would imply a compound annual growth rate (CAGR) of 13.96%. Finally, we may see a sector rotation away from tech and toward the healthcare arena. If so, that would likely benefit the below biotech stocks to buy.

https://investorplace.com/2024/06/7-biotech-stocks-to-boost-your-portfolio-to-peak-health/

Boston Scientific ( BSX ) DBS Programming Software Gets CE Mark

Boston Scientific (BSX) secures CE Mark for the DBS image-guided programming software, Vercise Neural Navigator 5.

https://www.zacks.com/stock/news/2293742/boston-scientific-bsx-dbs-programming-software-gets-ce-mark

Trending Today

ON Semiconductor Corporation ($ON) Stock Forecast: Up 0.4% Today

Floki ($FLOKI) Crypto Forecast: Down 7.5% Today

Reddit Inc ($RDDT) Stock Forecast: Up 5.6% Today

Rocket Companies Inc ($RKT) Stock Forecast: Up 5.1% Today

Polygon ($MATIC) Crypto Forecast: Down 5.1% Today

Nikola corporation ($NKLA) Stock Forecast: Down 6.3% Today

Worldcoin ($WLD) Crypto Forecast: Up 9.0% Today

Jupiter ($JUP) Crypto Forecast: Down 5.5% Today

Sirius XM Holdings Inc. ($SIRI) Stock Forecast: Up 15.3% Today

Tesla Inc. ($TSLA) Stock Forecast: Up 6.5% Today

Boston Scientific Corporation Price History

07.05.2024 - BSX Stock was up 1.9%

• Boston Scientific's stock showed a strong upward trend today, closing at $76.12, reflecting a +0.3% increase compared to the previous day.
• Concerns may have arisen initially due to an EVP selling over $500k in company stock; however, the overall positive market outlook and the company's solid fundamentals likely mitigated any apprehensions among investors.
• The company's consistent market outperformance over the last 15 years, with an average annual return of 14.9%, is a contributing factor to the high level of confidence and interest from investors.
• With an improved SmartSelect Composite Rating of 96, signaling that it is surpassing 96% of all stocks based on key criteria, Boston Scientific continues to receive favorable market sentiment.

24.03.2024 - BSX Stock was up 5.8%

• Boston Scientific (BSX) had a strong bullish movement today.
• This upward trend is linked to the company surpassing expectations in its first-quarter earnings report and providing optimistic guidance.
• First-quarter revenues of $3.86 billion exceeded the consensus estimate of $3.69 billion, demonstrating robust performance in core business areas.
• Shareholders responded positively to the positive earnings report, propelling the stock to achieve a 52-week high as they view Boston Scientific as a promising investment opportunity within the medical products industry.

24.03.2024 - BSX Stock was up 8.4%

• Boston Scientific (BSX) reported Q1 earnings and revenues that surpassed estimates, indicating strong financial performance and market confidence in the company's growth prospects.
• The positive earnings report and exceeding sales expectations propelled Boston Scientific's stock into buy zones, attracting investors and driving the bullish movement.
• The overall bullish market sentiment, with US broader indices up over 1% and stocks rising for the second consecutive day, also contributed to the upward momentum of BSX.
• Additionally, Boston Scientific received an IBD stock rating upgrade, further boosting investor confidence and interest in the company's stock.

11.02.2024 - BSX Stock was down 1.5%

• The stock of Boston Scientific (BSX) experienced a bearish movement despite being upgraded to a "buy" rating.
• The allegations against a former employee involved in a disturbing case of child abuse may have negatively impacted investor sentiment and contributed to the stock's decline.
• Despite the negative news surrounding the company, Boston Scientific has shown strong long-term performance, with a $1000 investment 10 years ago yielding significant returns.
• The market may have reacted to the news about Align Technology's improving technical performance, leading investors to shift focus away from Boston Scientific temporarily.

27.10.2023 - BSX Stock was down 1.0%

• The bearish movement in BSX's stock today could be attributed to several factors:
• 1. Profit-taking: After a significant increase in the stock price over the past month and year, some investors may have decided to sell their shares and take profits, leading to a downward pressure on the stock.
• 2. Market sentiment: The overall market sentiment towards healthcare stocks may have turned negative, causing investors to sell off their positions in BSX and other healthcare companies.
• 3. Lack of positive news: While there have been recent acquisitions and advancements mentioned in the news articles, there may not have been any specific positive news or developments directly impacting BSX today, leading to a lack of catalysts to drive the stock price higher.
• 4. Technical factors: The stock's price movement could also be influenced by technical factors, such as resistance levels or trading patterns, which may have triggered selling pressure.
• Overall, the bearish movement in BSX's stock today could be a result of profit-taking, negative market sentiment, lack of positive news, and technical factors.

13.10.2023 - BSX Stock was up 2.8%

• Short interest in BSX has fallen, indicating a decrease in bearish sentiment towards the stock.
• Positive investor sentiment is driven by growing demand for WATCHMAN FLX devices and upbeat guidance.
• Decreased stock position by Diamond Hill Capital Management suggests a potential reduction in selling pressure.
• The company's focus on AI innovations in the medtech industry, as highlighted by Sandra Nagale, may have contributed to positive market sentiment.

11.09.2023 - BSX Stock was down 5.1%

• The bearish movement in BSX today can be attributed to the following factors:
• 1. Profit-taking: After a period of consistent growth, investors may have decided to take profits, leading to a sell-off in the stock.
• 2. Market correction: The overall market may have experienced a downward trend, causing a negative impact on BSX and other stocks.
• 3. Technical factors: The technical benchmark of Integer Holdings, a competitor in the medical device industry, hitting an 80-plus RS rating may have drawn some investors' attention away from BSX, resulting in a decline in its stock price.
• Please note that the provided articles do not directly mention the bearish movement of BSX today.

11.09.2023 - BSX Stock was down 2.1%

• The bearish movement in BSX today can be attributed to a combination of factors:
• 1. Technical Benchmark: an article from Investors Business Daily mentions that Integer Holdings, a competitor in the medical technology industry, has cleared a technical benchmark, indicating positive market sentiment towards their stock. This could have led investors to shift their focus away from BSX, resulting in a bearish movement.
• 2. Short Interest: an article from Benzinga highlights a decrease in BSX's short percent of float, indicating a reduction in bearish bets against the stock. However, the presence of short sellers could still be impacting the stock's performance, contributing to the bearish movement.
• 3. Value Comparison: an article from Zacks Commentary compares the value of BSX to another stock, PBH. If investors perceive PBH as a better value option, they may have chosen to reallocate their investments, causing a decline in BSX's price.
• Overall, the bearish movement in BSX today can be attributed to factors such as market sentiment towards competitors, short interest, and value comparisons with other stocks.

28.07.2023 - BSX Stock was up 1.5%

• The bullish movement in BSX stock today can be attributed to several factors:
• 1. Positive study results: The ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System meeting primary efficacy and safety endpoints, presented at ESC Congress 2023 and published in The New England Journal of Medicine, likely boosted investor confidence in the company's innovative medical technology.
• 2. Global expansion: Boston Scientific's expansion of its Endoscopy business within MedSurg, driven by strong worldwide demand for its GI and pulmonary treatment options, indicates potential growth opportunities for the company.
• 3. Upgraded rating: Despite the downgrade by StockNews.com from a "buy" rating to a "hold" rating, other research analysts have issued positive research reports about the stock, suggesting that the overall sentiment towards BSX remains optimistic.
• 4. Strong financial performance: Boston Scientific's 56% increase in profit and an 81 RS rating after a year of growth may have attracted investors looking for high-performance portfolios.
• Overall, the bullish movement in BSX stock today can be attributed to positive study results, global expansion, positive research reports, and strong financial performance.

28.06.2023 - BSX Stock was down 3.0%

• The bearish movement in BSX today can be attributed to a combination of factors:
• 1. Raised profit forecast: Despite raising its annual profit forecast, the market may have had higher expectations for Boston Scientific's earnings, leading to a sell-off.
• 2. Mixed performance in the medical sector: The comparison with other medical stocks, such as DexCom (DXCM), which may have been performing better, could have influenced the bearish sentiment towards BSX.
• 3. General market sentiment: The overall market sentiment, as indicated by the article mentioning other stocks declaring earnings, could have played a role in the bearish movement of BSX today.